Neurocrine Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NBIX Nasdaq 2836 https://www.neurocrine.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neurocrine Biosciences, Inc.

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results - Apr 10th, 2024 8:01 pm
11 Best Biotech ETFs To Buy - Apr 9th, 2024 11:37 am
Is Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Recent Performance Tethered To Its Attractive Financial Prospects? - Apr 3rd, 2024 2:36 pm
Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder - Apr 3rd, 2024 12:30 pm
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adults - Mar 28th, 2024 12:30 pm
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind - Mar 23rd, 2024 12:00 pm
Dow Jones Futures: Apple Sour, But These 11 Stocks Flash Buy Signals; FedEx Soars - Mar 22nd, 2024 11:25 am
AI Plays HubSpot, Arista Networks Lead Five Stocks Near Buy Points In Classic Base - Mar 16th, 2024 12:00 pm
Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells 3,000 Shares - Mar 16th, 2024 5:23 am
Director Richard Pops Sells 23,200 Shares of Neurocrine Biosciences Inc (NBIX) - Mar 16th, 2024 5:23 am
Neurocrine Biosciences Is Pioneering Therapies for Neurological Disorders - Mar 15th, 2024 2:00 pm
Director Richard Pops Sells Shares of Neurocrine Biosciences Inc (NBIX) - Mar 13th, 2024 5:26 am
Neurocrine Biosciences to Participate at Virtual Investor Conferences in March - Mar 11th, 2024 8:01 pm
The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher - Mar 11th, 2024 5:12 pm
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success - Mar 6th, 2024 9:45 pm
Neurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells Company Shares - Mar 1st, 2024 5:40 am
Neurocrine Biosciences to Participate at Investor Conferences in March - Feb 27th, 2024 9:01 pm
Director Richard Pops Sells 15,000 Shares of Neurocrine Biosciences Inc - Feb 23rd, 2024 4:28 am
11 Best Small-Cap Growth Stocks to Invest In - Feb 22nd, 2024 8:55 am
Neurocrine Biosciences Inc's Chief Commercial Officer Eric Benevich Sells Company Shares - Feb 16th, 2024 4:36 am